Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia
Neil Kidambi,* Omar H Elsayed,* Rif S El-Mallakh* Mood Disorders Research Program, Depression Center, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, 40202, USA*These authors contributed equally to this wo...
Main Authors: | Kidambi N, Elsayed OH, El-Mallakh RS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-05-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/xanomeline-trospium-and-muscarinic-involvement-in-schizophrenia-peer-reviewed-fulltext-article-NDT |
Similar Items
-
Tiotropium: efficacy and safety in pediatric bronchial asthma
by: Natalia G. Kolosova, et al.
Published: (2021-03-01) -
The use of short-acting bronchodilators in patients with chronic bronchoobstructive pathology at the present stage
by: K. A. Zykov, et al.
Published: (2021-09-01) -
Effects of (a Combination of) the Beta<sub>2</sub>-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction
by: Harm Maarsingh, et al.
Published: (2021-05-01) -
Pharmacological Modulation of Endotoxin-Induced Release of IL-26 in Human Primary Lung Fibroblasts
by: Karlhans Fru Che, et al.
Published: (2019-08-01) -
Mixed urinary incontinence: a current view at the problem (review of clinical guidelines)
by: E I Ermakova
Published: (2018-08-01)